(1S,4S,5R)-3-((2S)-2-(TERT-BUTYLCARBAMOYLAMINO)-3,3-DIMETHYL-BUTANOYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXANE-4-CARBOXAMIDE
UNII VDR39B9LAQ
Substance Identification & Data
This profile provides standardized clinical and technical data for (1s,4s,5r)-3-((2s)-2-(tert-butylcarbamoylamino)-3,3-dimethyl-butanoyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-4-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VDR39B9LAQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1351791-45-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H34N4O3 MUNKKBLZOYMWMX-ZDEQEGDKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (1s,4s,5r)-3-((2s)-2-(tert-butylcarbamoylamino)-3,3-dimethyl-butanoyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-4-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.